Tehran (IP) - Iran's head of Food and Drug Administration Mohamad-Reza Shanesaz said that Remdesivir will be exported after the country's needs have been met.

Iran Press/Iran News: In response to Iran Press' question on the effectiveness of Remdesivir medicine and its exporting process, he stated although several treatment methods have been tried to cure the coronavirus disease (COVID-19), none have yet been shown to be efficacious.

Remdesivir is one of the medicines which have been used to treat the virus but its effect is not high, Mohamad-Reza Shanesaz pointed out.

Iran's head of Food and Drug Administration added four pharmaceutical companies have applied for Remdesivir production and two of these have started to produce the medicine.

He noted this medicine will be actively entered the market this week.

Yet its raw materials are not produced in the country but soon will be, he said.

Speaking at the press conference, he said that no definitive medicine has yet been introduced in the world to cure the virus.

All seemed to be effective medicines to treat the disease that has been dispensed in the country such as an anti-inflammatory or anti-viral and the raw materials of many of these medicines are produced in the country or knowledge-based companies have announced their readiness to produce their raw materials, he highlighted.

As for Remdesivir, he stressed that as soon as this drug entered the official list of the country and its import was allowed, it has been distributed to universities and heads of universities and hospitals.

He added that patients should get this medicine only from hospitals, pharmacies, and medical universities.


Read More:

Over 293 k recovered from COVID-19 so far: Health Ministry spox.

Over 292 k recovered from COVID-19: Iran's Health Ministry Spox